Cargando…

Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy

BACKGROUND AND AIMS: Oral xerostomia remains one of the most common complications of differentiated thyroid carcinoma patients (DTC) after radioiodine therapy (RAI). Environmental factors in the etiology of xerostomia are largely unknown. We aimed to characterize the oral microbiota signatures and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Baiqiang, Zhao, Fuya, Liu, Yang, Sun, Jiayu, Feng, Jing, Zhao, Lei, Wang, Haoran, Chen, Hongye, Yan, Wei, Guo, Xiao, Shi, Shang, Li, Zhiyong, Wang, Shuang, Lu, Yu, Zheng, Jianjun, Wei, Yunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459331/
https://www.ncbi.nlm.nih.gov/pubmed/36093087
http://dx.doi.org/10.3389/fendo.2022.895970
_version_ 1784786487625121792
author Lin, Baiqiang
Zhao, Fuya
Liu, Yang
Sun, Jiayu
Feng, Jing
Zhao, Lei
Wang, Haoran
Chen, Hongye
Yan, Wei
Guo, Xiao
Shi, Shang
Li, Zhiyong
Wang, Shuang
Lu, Yu
Zheng, Jianjun
Wei, Yunwei
author_facet Lin, Baiqiang
Zhao, Fuya
Liu, Yang
Sun, Jiayu
Feng, Jing
Zhao, Lei
Wang, Haoran
Chen, Hongye
Yan, Wei
Guo, Xiao
Shi, Shang
Li, Zhiyong
Wang, Shuang
Lu, Yu
Zheng, Jianjun
Wei, Yunwei
author_sort Lin, Baiqiang
collection PubMed
description BACKGROUND AND AIMS: Oral xerostomia remains one of the most common complications of differentiated thyroid carcinoma patients (DTC) after radioiodine therapy (RAI). Environmental factors in the etiology of xerostomia are largely unknown. We aimed to characterize the oral microbiota signatures and related biological functions associated with xerostomia and identify environmental factors affecting them. METHODS: Saliva was collected from 30 DTC patients with xerostomia (XAs), 32 patients without xerostomia (indicated as non-XAs) following RAI after total thyroidectomy, and 40 healthy people (HCs) for 16S rRNA sequencing analysis. RESULTS: The oral microbiota of XAs and non-XAs exhibited significant differences in α and β diversities and bacterial taxa. The abundance of porphyromonas, fusobacterium, and treponema_2 were significantly higher in XAs, while the abundance of the streptococcus was lower in the microbiota of non-XAs. Fusobacterium, and porphyromonas were negatively correlated with unstimulated/stimulated whole salivary secretion (USW)/(SWS), while fusobacterium, porphyromonas, and treponema_2 genera levels were positively associated with cumulative radioiodine dose. PICRUSt2 and BugBase suggested a significant difference in the expression of potentially_pathogenic, anaerobic, gram_negative, the arachidonic acid metabolism, and lipopolysaccharide (LPS) biosynthesis between XAs and non-XAs, possibly interdependent on radioiodine-induced inflammation. NetShift analysis revealed that porphyromonas genus might play as a key driver during the process of xerostomia. Five genera effectively distinguished XAs from non-XAs (AUC = 0.87). CONCLUSION: Our study suggests for the first time that DTC patients with xerostomia after RAI display microbiota profiles and associated functional changes that may promote a pro-inflammatory environment. Dysbiosis of the oral microbiota may contribute to exacerbating the severity of xerostomia. Our results provide a research direction of the interaction mechanism between oral microbiota alteration and the progress of xerostomia.
format Online
Article
Text
id pubmed-9459331
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94593312022-09-10 Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy Lin, Baiqiang Zhao, Fuya Liu, Yang Sun, Jiayu Feng, Jing Zhao, Lei Wang, Haoran Chen, Hongye Yan, Wei Guo, Xiao Shi, Shang Li, Zhiyong Wang, Shuang Lu, Yu Zheng, Jianjun Wei, Yunwei Front Endocrinol (Lausanne) Endocrinology BACKGROUND AND AIMS: Oral xerostomia remains one of the most common complications of differentiated thyroid carcinoma patients (DTC) after radioiodine therapy (RAI). Environmental factors in the etiology of xerostomia are largely unknown. We aimed to characterize the oral microbiota signatures and related biological functions associated with xerostomia and identify environmental factors affecting them. METHODS: Saliva was collected from 30 DTC patients with xerostomia (XAs), 32 patients without xerostomia (indicated as non-XAs) following RAI after total thyroidectomy, and 40 healthy people (HCs) for 16S rRNA sequencing analysis. RESULTS: The oral microbiota of XAs and non-XAs exhibited significant differences in α and β diversities and bacterial taxa. The abundance of porphyromonas, fusobacterium, and treponema_2 were significantly higher in XAs, while the abundance of the streptococcus was lower in the microbiota of non-XAs. Fusobacterium, and porphyromonas were negatively correlated with unstimulated/stimulated whole salivary secretion (USW)/(SWS), while fusobacterium, porphyromonas, and treponema_2 genera levels were positively associated with cumulative radioiodine dose. PICRUSt2 and BugBase suggested a significant difference in the expression of potentially_pathogenic, anaerobic, gram_negative, the arachidonic acid metabolism, and lipopolysaccharide (LPS) biosynthesis between XAs and non-XAs, possibly interdependent on radioiodine-induced inflammation. NetShift analysis revealed that porphyromonas genus might play as a key driver during the process of xerostomia. Five genera effectively distinguished XAs from non-XAs (AUC = 0.87). CONCLUSION: Our study suggests for the first time that DTC patients with xerostomia after RAI display microbiota profiles and associated functional changes that may promote a pro-inflammatory environment. Dysbiosis of the oral microbiota may contribute to exacerbating the severity of xerostomia. Our results provide a research direction of the interaction mechanism between oral microbiota alteration and the progress of xerostomia. Frontiers Media S.A. 2022-08-26 /pmc/articles/PMC9459331/ /pubmed/36093087 http://dx.doi.org/10.3389/fendo.2022.895970 Text en Copyright © 2022 Lin, Zhao, Liu, Sun, Feng, Zhao, Wang, Chen, Yan, Guo, Shi, Li, Wang, Lu, Zheng and Wei https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Lin, Baiqiang
Zhao, Fuya
Liu, Yang
Sun, Jiayu
Feng, Jing
Zhao, Lei
Wang, Haoran
Chen, Hongye
Yan, Wei
Guo, Xiao
Shi, Shang
Li, Zhiyong
Wang, Shuang
Lu, Yu
Zheng, Jianjun
Wei, Yunwei
Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy
title Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy
title_full Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy
title_fullStr Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy
title_full_unstemmed Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy
title_short Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy
title_sort alterations in oral microbiota of differentiated thyroid carcinoma patients with xerostomia after radioiodine therapy
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459331/
https://www.ncbi.nlm.nih.gov/pubmed/36093087
http://dx.doi.org/10.3389/fendo.2022.895970
work_keys_str_mv AT linbaiqiang alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy
AT zhaofuya alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy
AT liuyang alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy
AT sunjiayu alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy
AT fengjing alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy
AT zhaolei alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy
AT wanghaoran alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy
AT chenhongye alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy
AT yanwei alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy
AT guoxiao alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy
AT shishang alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy
AT lizhiyong alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy
AT wangshuang alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy
AT luyu alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy
AT zhengjianjun alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy
AT weiyunwei alterationsinoralmicrobiotaofdifferentiatedthyroidcarcinomapatientswithxerostomiaafterradioiodinetherapy